1863 related articles for article (PubMed ID: 30883053)
21. Safety and Efficacy of Self-Expanding TAVR in Patients With Aortoventricular Angulation.
Popma JJ; Reardon MJ; Yakubov SJ; Hermiller JB; Harrison JK; Gleason TG; Conte JV; Deeb GM; Chetcuti S; Oh JK; Boulware MJ; Huang J; Adams DH;
JACC Cardiovasc Imaging; 2016 Aug; 9(8):973-81. PubMed ID: 27491485
[TBL] [Abstract][Full Text] [Related]
22. Transcatheter aortic valve replacement versus surgery for symptomatic severe aortic stenosis: A reconstructed individual patient data meta-analysis.
Dowling C; Kondapally Seshasai SR; Firoozi S; Brecker SJ
Catheter Cardiovasc Interv; 2020 Jul; 96(1):158-166. PubMed ID: 31566902
[TBL] [Abstract][Full Text] [Related]
23. Durability and Clinical Outcomes of Transcatheter Aortic Valve Replacement for Failed Surgical Bioprostheses.
Dauerman HL; Deeb GM; O'Hair DP; Waksman R; Yakubov SJ; Kleiman NS; Chetcuti SJ; Hermiller JB; Bajwa T; Khabbaz K; de Marchena E; Salerno T; Dries-Devlin JL; Li S; Popma JJ; Reardon MJ
Circ Cardiovasc Interv; 2019 Oct; 12(10):e008155. PubMed ID: 31607151
[TBL] [Abstract][Full Text] [Related]
24. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery.
Popma JJ; Adams DH; Reardon MJ; Yakubov SJ; Kleiman NS; Heimansohn D; Hermiller J; Hughes GC; Harrison JK; Coselli J; Diez J; Kafi A; Schreiber T; Gleason TG; Conte J; Buchbinder M; Deeb GM; Carabello B; Serruys PW; Chenoweth S; Oh JK;
J Am Coll Cardiol; 2014 May; 63(19):1972-81. PubMed ID: 24657695
[TBL] [Abstract][Full Text] [Related]
25. Mid-term outcomes of Sapien 3 versus Perimount Magna Ease for treatment of severe aortic stenosis.
Virtanen MPO; Eskola M; Savontaus M; Juvonen T; Niemelä M; Laakso T; Husso A; Jalava MP; Tauriainen T; Ahvenvaara T; Maaranen P; Kinnunen EM; Dahlbacka S; Laine M; Mäkikallio T; Valtola A; Raivio P; Rosato S; D'Errigo P; Vento A; Airaksinen J; Biancari F
J Cardiothorac Surg; 2020 Jun; 15(1):157. PubMed ID: 32600369
[TBL] [Abstract][Full Text] [Related]
26. Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients: 5-Year Outcomes of the SURTAVI Randomized Clinical Trial.
Van Mieghem NM; Deeb GM; Søndergaard L; Grube E; Windecker S; Gada H; Mumtaz M; Olsen PS; Heiser JC; Merhi W; Kleiman NS; Chetcuti SJ; Gleason TG; Lee JS; Cheng W; Makkar RR; Crestanello J; George B; George I; Kodali S; Yakubov SJ; Serruys PW; Lange R; Piazza N; Williams MR; Oh JK; Adams DH; Li S; Reardon MJ;
JAMA Cardiol; 2022 Oct; 7(10):1000-1008. PubMed ID: 36001335
[TBL] [Abstract][Full Text] [Related]
27. 3-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis.
Forrest JK; Deeb GM; Yakubov SJ; Gada H; Mumtaz MA; Ramlawi B; Bajwa T; Teirstein PS; DeFrain M; Muppala M; Rutkin BJ; Chawla A; Jenson B; Chetcuti SJ; Stoler RC; Poulin MF; Khabbaz K; Levack M; Goel K; Tchétché D; Lam KY; Tonino PAL; Ito S; Oh JK; Huang J; Popma JJ; Kleiman N; Reardon MJ;
J Am Coll Cardiol; 2023 May; 81(17):1663-1674. PubMed ID: 36882136
[TBL] [Abstract][Full Text] [Related]
28. Early Clinical Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis Who Are Suboptimal for Surgery: Results of the Evolut R U.S. Study.
Popma JJ; Reardon MJ; Khabbaz K; Harrison JK; Hughes GC; Kodali S; George I; Deeb GM; Chetcuti S; Kipperman R; Brown J; Qiao H; Slater J; Williams MR
JACC Cardiovasc Interv; 2017 Feb; 10(3):268-275. PubMed ID: 28183466
[TBL] [Abstract][Full Text] [Related]
29. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis: 1-Year Results From the All-Comers NOTION Randomized Clinical Trial.
Thyregod HG; Steinbrüchel DA; Ihlemann N; Nissen H; Kjeldsen BJ; Petursson P; Chang Y; Franzen OW; Engstrøm T; Clemmensen P; Hansen PB; Andersen LW; Olsen PS; Søndergaard L
J Am Coll Cardiol; 2015 May; 65(20):2184-94. PubMed ID: 25787196
[TBL] [Abstract][Full Text] [Related]
30. Outcomes Following Transcatheter Aortic Valve Replacement for Degenerative Stentless Versus Stented Bioprostheses.
Duncan A; Moat N; Simonato M; de Weger A; Kempfert J; Eggebrecht H; Walton A; Hellig F; Kornowski R; Spargias K; Mendiz O; Makkar R; Guerrero M; Rihal C; George I; Don C; Iadanza A; Bapat V; Welsh R; Wijeysundera HC; Wood D; Sathananthan J; Danenberg H; Maisano F; Garcia S; Gafoor S; Nombela-Franco L; Cobiella J; Dvir D
JACC Cardiovasc Interv; 2019 Jul; 12(13):1256-1263. PubMed ID: 31202944
[TBL] [Abstract][Full Text] [Related]
31. TAVR for Failed Surgical Aortic Bioprostheses Using a Self-Expanding Device: 1-Year Results From the Prospective VIVA Postmarket Study.
Tchétché D; Chevalier B; Holzhey D; Harnath A; Schäfer U; Teiger E; Manigold T; Modine T; Souteyrand G; Champagnac D; Oh JK; Li S; Verhoye JP; Kornowski R;
JACC Cardiovasc Interv; 2019 May; 12(10):923-932. PubMed ID: 31122349
[TBL] [Abstract][Full Text] [Related]
32. Longitudinal Hemodynamics of Transcatheter and Surgical Aortic Valves in the PARTNER Trial.
Douglas PS; Leon MB; Mack MJ; Svensson LG; Webb JG; Hahn RT; Pibarot P; Weissman NJ; Miller DC; Kapadia S; Herrmann HC; Kodali SK; Makkar RR; Thourani VH; Lerakis S; Lowry AM; Rajeswaran J; Finn MT; Alu MC; Smith CR; Blackstone EH;
JAMA Cardiol; 2017 Nov; 2(11):1197-1206. PubMed ID: 28973520
[TBL] [Abstract][Full Text] [Related]
33. A Comparative Study of TAVR versus SAVR in Moderate and High-Risk Surgical Patients: Hospital Outcome and Midterm Results.
Abdelgawad AME; Hussein MA; Naeim H; Abuelatta R; Alghamdy S
Heart Surg Forum; 2019 Aug; 22(5):E331-E339. PubMed ID: 31596707
[TBL] [Abstract][Full Text] [Related]
34. Outcomes of Redo Transcatheter Aortic Valve Replacement for the Treatment of Postprocedural and Late Occurrence of Paravalvular Regurgitation and Transcatheter Valve Failure.
Barbanti M; Webb JG; Tamburino C; Van Mieghem NM; Makkar RR; Piazza N; Latib A; Sinning JM; Won-Keun K; Bleiziffer S; Bedogni F; Kapadia S; Tchetche D; Rodés-Cabau J; Fiorina C; Nombela-Franco L; De Marco F; de Jaegere PP; Chakravarty T; Vaquerizo B; Colombo A; Svensson L; Lange R; Nickenig G; Möllmann H; Walther T; Della Rosa F; Elhmidi Y; Dvir D; Brambilla N; Immè S; Sgroi C; Gulino S; Todaro D; Pilato G; Petronio AS; Tamburino C
Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27578840
[TBL] [Abstract][Full Text] [Related]
35. Mitral regurgitation in patients undergoing transcatheter aortic valve implantation for degenerated surgical aortic bioprosthesis: Insights from PARTNER 2 Valve-in-Valve Registry.
Murdoch DJ; Sathananthan J; Hensey M; Alu MC; Liu Y; Crowley A; Wood D; Cheung A; Ye J; Feldman T; Hahn RT; Jaber WA; Mack MJ; Malaisrie SC; Leon MB; Webb JG
Catheter Cardiovasc Interv; 2020 Oct; 96(4):981-986. PubMed ID: 32118351
[TBL] [Abstract][Full Text] [Related]
36. Regression of Paravalvular Aortic Regurgitation and Remodeling of Self-Expanding Transcatheter Aortic Valve: An Observation From the CoreValve U.S. Pivotal Trial.
Oh JK; Little SH; Abdelmoneim SS; Reardon MJ; Kleiman NS; Lin G; Bach D; Gillam L; Kar B; Coselli J; Sengupta PP; Grewal K; Chang J; Chang Y; Boulware M; Adams DH; Popma JJ;
JACC Cardiovasc Imaging; 2015 Dec; 8(12):1364-1375. PubMed ID: 26508386
[TBL] [Abstract][Full Text] [Related]
37. 3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement.
Deeb GM; Reardon MJ; Chetcuti S; Patel HJ; Grossman PM; Yakubov SJ; Kleiman NS; Coselli JS; Gleason TG; Lee JS; Hermiller JB; Heiser J; Merhi W; Zorn GL; Tadros P; Robinson N; Petrossian G; Hughes GC; Harrison JK; Maini B; Mumtaz M; Conte J; Resar J; Aharonian V; Pfeffer T; Oh JK; Qiao H; Adams DH; Popma JJ;
J Am Coll Cardiol; 2016 Jun; 67(22):2565-74. PubMed ID: 27050187
[TBL] [Abstract][Full Text] [Related]
38. Early Outcomes for Valve-in-valve Transcatheter Aortic Valve Replacement in Degenerative Freestyle Bioprostheses.
Sang SLW; Beute T; Heiser J; Berkompas D; Fanning J; Merhi W
Semin Thorac Cardiovasc Surg; 2018 Autumn; 30(3):262-268. PubMed ID: 29158054
[TBL] [Abstract][Full Text] [Related]
39. Health Status After Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Increased Surgical Risk: Results From the CoreValve US Pivotal Trial.
Arnold SV; Reynolds MR; Wang K; Magnuson EA; Baron SJ; Chinnakondepalli KM; Reardon MJ; Tadros PN; Zorn GL; Maini B; Mumtaz MA; Brown JM; Kipperman RM; Adams DH; Popma JJ; Cohen DJ;
JACC Cardiovasc Interv; 2015 Aug; 8(9):1207-1217. PubMed ID: 26292584
[TBL] [Abstract][Full Text] [Related]
40. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis.
Makkar RR; Fontana GP; Jilaihawi H; Kapadia S; Pichard AD; Douglas PS; Thourani VH; Babaliaros VC; Webb JG; Herrmann HC; Bavaria JE; Kodali S; Brown DL; Bowers B; Dewey TM; Svensson LG; Tuzcu M; Moses JW; Williams MR; Siegel RJ; Akin JJ; Anderson WN; Pocock S; Smith CR; Leon MB;
N Engl J Med; 2012 May; 366(18):1696-704. PubMed ID: 22443478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
